Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Yoshida

Showing results (231-240 of 341) with videos related to

Pageof 35
Sort By:
Canadian Journal of Gastroenterology & Hepatology|March 25, 2015
Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British ColumbiaVictoria Yui-Min Kan, Vladimir Marquez Azalgara, Jo-Ann E Ford, et al.
Annals of Hepatology|February 18, 2009
Surgical morbidity in severely obese liver transplant recipients - a single Canadian Centre ExperienceDavid F Schaeffer, Eric M Yoshida, Andrej K Buczkowski, et al.
Cancer Medicine|August 10, 2017
Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian settingHla-Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, et al.
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
Aging|October 10, 2019
Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosisZhaohui Bai, Mauro Bernardi, Eric M Yoshida, et al.
Canadian Liver Journal|May 14, 2026
Development and evaluation of machine learning models for predicting significant liver fibrosis stages: A retrospective analysisNicholas W Tjandra, David Mp Di Fonzo, Tianyi Wen, et al.
European Journal of Gastroenterology & Hepatology|March 23, 2017
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre studyPaolo Muratori, Cumali Efe, Luigi Muratori, et al.
Hepatology Communications|August 8, 2019
Patients' Perspectives on Early Liver Transplantation in Alcohol-Related Liver DiseaseEric Wong, Paul D Mullins, Jean-Philippe Wallach, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 19, 2016
Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics StudyRaymond A Rubin, Mark W Russo, Kimberly A Brown, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 12, 2015
Seroprevalences of hepatitis B virus and hepatitis C virus among participants of an Asian health fair in the Lower Mainland, British ColumbiaStephen Ip, Jo-Ann Ford, Kirby Lau, et al.
Pageof 35

Showing results (231-240 of 341) with videos related to

Sort By:
Pageof 35
Canadian Journal of Gastroenterology & Hepatology|March 25, 2015
Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British ColumbiaVictoria Yui-Min Kan, Vladimir Marquez Azalgara, Jo-Ann E Ford, et al.
Annals of Hepatology|February 18, 2009
Surgical morbidity in severely obese liver transplant recipients - a single Canadian Centre ExperienceDavid F Schaeffer, Eric M Yoshida, Andrej K Buczkowski, et al.
Cancer Medicine|August 10, 2017
Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian settingHla-Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, et al.
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
Aging|October 10, 2019
Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosisZhaohui Bai, Mauro Bernardi, Eric M Yoshida, et al.
Canadian Liver Journal|May 14, 2026
Development and evaluation of machine learning models for predicting significant liver fibrosis stages: A retrospective analysisNicholas W Tjandra, David Mp Di Fonzo, Tianyi Wen, et al.
European Journal of Gastroenterology & Hepatology|March 23, 2017
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre studyPaolo Muratori, Cumali Efe, Luigi Muratori, et al.
Hepatology Communications|August 8, 2019
Patients' Perspectives on Early Liver Transplantation in Alcohol-Related Liver DiseaseEric Wong, Paul D Mullins, Jean-Philippe Wallach, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 19, 2016
Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics StudyRaymond A Rubin, Mark W Russo, Kimberly A Brown, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 12, 2015
Seroprevalences of hepatitis B virus and hepatitis C virus among participants of an Asian health fair in the Lower Mainland, British ColumbiaStephen Ip, Jo-Ann Ford, Kirby Lau, et al.
Pageof 35